Project Details
Description
A phase I/II trial of CLT-008 myeloid progenitor cells in patients receiving post-remission therapy for high risk leukemia or myelodysplasia
| Status | Finished |
|---|---|
| Effective start/end date | 11/17/11 → 8/31/15 |
Funding
- CELLERANT THERAPEUTICS, INC.
- U.S. DEPARTMENT OF HEALTH & HUMAN SVCS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.